Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss

dc.contributor.authorBantulà, Marina
dc.contributor.authorTubita, Valeria
dc.contributor.authorRoca Ferrer, Jordi
dc.contributor.authorMullol i Miret, Joaquim
dc.contributor.authorValero, Antonio
dc.contributor.authorBobolea, Irina
dc.contributor.authorPascal i Capdevila, Mariona
dc.contributor.authorHollanda Ramírez, Ana M. de
dc.contributor.authorVidal, Josep
dc.contributor.authorPicado Vallés, César
dc.contributor.authorArismendi, Ebymar
dc.date.accessioned2023-06-21T09:57:40Z
dc.date.available2023-06-21T09:57:40Z
dc.date.issued2022-06-29
dc.date.updated2023-06-20T10:44:35Z
dc.description.abstractObesity and asthma are associated with systemic inflammation maintained by mediators released by adipose tissue and lung. This study investigated the inflammatory serum mediator profile in obese subjects (O) (n = 35), non-obese asthma (NOA) patients (n = 14), obese asthmatics (OA) (n = 21) and healthy controls (HC) (n = 33). The effect of weight loss after bariatric surgery (BS) was examined in 10 OA and 31 O subjects. We analyzed serum markers including leptin, adiponectin, TGF-?1, TNFR2, MCP-1, ezrin, YKL-40, ST2, IL-5, IL-9, and IL-18. Compared with HC subjects, the O group showed increased levels of leptin, TGF-?1, TNFR2, MCP-1, ezrin, YKL-40, and ST2; the OA group presented increased levels of MCP-1, ezrin, YKL-40, and IL-18, and the NOA group had increased levels of ezrin, YKL-40, IL-5, and IL-18. The higher adiponectin/leptin ratio in NOA with respect to OA subjects was the only significant difference between the two groups. IL-9 was the only cytokine with significantly higher levels in OA with respect to O subjects. TNFR2, ezrin, MCP-1, and IL-18 concentrations significantly decreased in O subjects after BS. O, OA, and NOA showed distinct patterns of systemic inflammation. Leptin and adiponectin are regulated in asthma by obesity-dependent and-independent mechanisms. Combination of asthma and obesity does not result in significant additive effects on circulating cytokine levels. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
dc.format.extent19 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9330620
dc.identifier.issn2077-0383
dc.identifier.pmid35807067
dc.identifier.urihttps://hdl.handle.net/2445/199582
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/jcm11133782
dc.relation.ispartofJournal Of Clinical Medicine, 2022, vol. 11, num. 13
dc.relation.urihttps://doi.org/10.3390/jcm11133782
dc.rightscc by (c) Bantulà, Marina et al, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationAsma
dc.subject.classificationObesitat
dc.subject.otherAsthma
dc.subject.otherObesity
dc.titleDifferences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Differences in Inflammatory Cytokine Profile in_ClinicalMedicine.pdf
Mida:
1.03 MB
Format:
Adobe Portable Document Format